SS&C(US:SSNC)2025-07-23 22:02Financial Data and Key Metrics Changes - The company reported record adjusted revenue of $1,537 million, an increase of 5.9% year-over-year, and adjusted earnings per share of $1.45, a 9.8% increase [5][13] - Adjusted consolidated EBITDA reached $600 million for the first time, up 7.4%, resulting in a quarterly adjusted consolidated EBITDA margin of 39% [5][14] - Cash from operating activities for the six months ended June 30, 2025, was $645.1 million, up 14% year-over-year [8][14] Business Line Data and Key Metrics Changes - GLOBAB experienced organic growth of 7.3%, driven by double-digit growth in private markets and retail alternatives [5][10] - The financial services recurring revenue growth was 3.9%, which includes software-enabled services and maintenance revenue [6] - The health segment reported flat organic growth for the quarter [6] Market Data and Key Metrics Changes - Internationally, the company saw strength in Europe, Australia, and the Middle East, reflecting a positive trend of increased international win rates [6][7] - The company noted that early indicators show activity is picking up in the second half of the year, despite macroeconomic challenges faced in the first half [12][68] Company Strategy and Development Direction - The company is focused on continuous investment in its AI strategy, believing that partnerships with Blue Prism will enhance its competitive advantages [8][65] - A definitive agreement to acquire Callistone was announced, expected to close in Q4 2025, which is anticipated to be accretive to revenue growth, EBITDA margin, and EPS within twelve months [17][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to overcome macroeconomic challenges due to the diversification of revenue across product lines and customer types [12] - The company raised its full-year revenue guidance by $15 million at the midpoint, now expecting revenue in the range of $6,143 million to $6,243 million [16] Other Important Information - The company repurchased 3.4 million shares for $269 million at an average price of $77.99, with a share repurchase authorization recently increased to $1.5 billion [8][14] - The effective non-GAAP tax rate was reported at 24% [14] Q&A Session Summary Question: Can you discuss the revenue synergy potential of the Callistone deal? - Management indicated that while it is early to quantify, there are significant cross-selling opportunities due to the client bases of both companies [19][20] Question: Why has the organic revenue outlook for the full year not changed despite strong Q2 performance? - Management clarified that expectations for the second half remain strong, and the overall organic growth for the year is still projected at 4.5% [28][29] Question: What is the comfortable level of leverage for potential future acquisitions? - Management stated a comfort level in the mid-fours for leverage, indicating readiness for significant acquisitions if opportunities arise [30][32] Question: What percentage of revenue comes from professional services, and is it a leading indicator? - Management explained that professional services are essential for building out technology for clients, typically leading to service contracts after initial projects [35][36] Question: What is the growth rate for the BATEA segment? - Management reported that BATEA is growing at a historical low double-digit growth rate, with expectations for seasonality in revenue [43][44] Question: Can you provide an update on the Blue Prism product lifecycle? - Management noted that Blue Prism is rolling out new features and has deployed thousands of digital workers, indicating a strong future outlook despite competitive pressures [64][65] Question: How significant has the degradation in deal counts been from the beginning of the year? - Management indicated that while there was a decline, early indicators show an uptick in bookings and deal counts, suggesting growth in the back half of the year [66][68]